| UNIQURE N.V. EO -,05 |
| Niederlande |
| Gesundheit |
| NL0010696654 / A1XDTV |
| UQ1 (Frankfurt) / QURE (NASDAQ) |
| FRA:UQ1, ETR:UQ1, UQ1:GR, NASDAQ:QURE |
| - |
| https://www.uniqure.com/ |
|
uniQure N.V. is a biopharmaceutical company specia..
>Volltext.. |
| 1345.15 Mio. EUR |
| 1206.6 Mio. EUR |
| 13.5 Mio. EUR |
| -151.61 Mio. EUR |
| -201.51 Mio. EUR |
| -3.76 EUR |
| 455.62 Mio. EUR |
| 511.66 Mio. EUR |
| -131.94 Mio. EUR |
| 6.9 |
| -47.72% |
| 6.84% |
| - |
| - |
| - |
| UNIQURE |
| 05.12.25 |